Financials Diagnostic Medical Systems

Equities

ALDMS

FR0012202497

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris 13:01:58 26/04/2024 BST 5-day change 1st Jan Change
1.04 EUR 0.00% Intraday chart for Diagnostic Medical Systems +4.63% -8.37%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 23.37 11.51 19.83 28.37 19.67 16.28
Enterprise Value (EV) 1 25.02 17.08 28.17 41.51 31.34 27.26
P/E ratio -9.04 x -2.13 x -6.39 x -5.33 x -5.08 x -2.39 x
Yield - - - - - -
Capitalization / Revenue 0.77 x 0.42 x 0.58 x 0.81 x 0.49 x 0.44 x
EV / Revenue 0.82 x 0.62 x 0.82 x 1.18 x 0.78 x 0.74 x
EV / EBITDA -7.7 x -3.61 x -8.23 x -14.1 x -65.6 x -4.32 x
EV / FCF -7.2 x -8.45 x -21.3 x -8.54 x -9.64 x -2.99 x
FCF Yield -13.9% -11.8% -4.7% -11.7% -10.4% -33.5%
Price to Book 1 x 0.64 x 1.35 x 1.67 x 1.05 x 1.04 x
Nbr of stocks (in thousands) 16,121 16,121 16,121 16,121 16,121 16,121
Reference price 2 1.450 0.7140 1.230 1.760 1.220 1.010
Announcement Date 30/04/18 01/08/19 20/05/20 31/05/21 29/04/22 28/04/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 30.41 27.6 34.16 35.24 39.99 37.06
EBITDA 1 -3.249 -4.731 -3.423 -2.954 -0.478 -6.305
EBIT 1 -3.585 -5.08 -3.797 -3.57 -0.905 -6.859
Operating Margin -11.79% -18.4% -11.12% -10.13% -2.26% -18.51%
Earnings before Tax (EBT) 1 -2.113 -5.453 -3.238 -5.535 -4.127 -6.639
Net income 1 -2.544 -5.4 -3.105 -5.24 -3.875 -6.82
Net margin -8.37% -19.56% -9.09% -14.87% -9.69% -18.4%
EPS 2 -0.1604 -0.3350 -0.1926 -0.3300 -0.2404 -0.4231
Free Cash Flow 1 -3.474 -2.021 -1.326 -4.858 -3.249 -9.123
FCF margin -11.42% -7.32% -3.88% -13.79% -8.13% -24.62%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 30/04/18 01/08/19 20/05/20 31/05/21 29/04/22 28/04/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 1.65 5.57 8.35 13.1 11.7 11
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.5066 x -1.177 x -2.438 x -4.446 x -24.41 x -1.741 x
Free Cash Flow 1 -3.47 -2.02 -1.33 -4.86 -3.25 -9.12
ROE (net income / shareholders' equity) -8.19% -26.5% -19.8% -34.7% -22% -34.5%
ROA (Net income/ Total Assets) -4.98% -8.26% -6.15% -5.18% -1.14% -8.02%
Assets 1 51.13 65.41 50.45 101.1 338.5 85.05
Book Value Per Share 2 1.460 1.120 0.9100 1.060 1.160 0.9700
Cash Flow per Share 2 0.2600 0.0700 0.0900 0.1100 0.2600 0.2700
Capex 1 3.28 3.36 3.38 3.08 5.88 2.6
Capex / Sales 10.78% 12.18% 9.88% 8.75% 14.71% 7%
Announcement Date 30/04/18 01/08/19 20/05/20 31/05/21 29/04/22 28/04/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ALDMS Stock
  4. Financials Diagnostic Medical Systems